Sector
TradingOpen
₹2.02Prev. Close
₹2.02Turnover(Lac.)
₹6.89Day's High
₹2.02Day's Low
₹1.9252 Week's High
₹4.3252 Week's Low
₹1.89Book Value
₹1.19Face Value
₹1Mkt Cap (₹ Cr.)
108.53P/E
40.4EPS
0.05Divi. Yield
027 Jun 2024
12:00 AM
AGM
Announcement Date: 27 Jun, 2024
19 Mar 2025
12:00 AM
Board Meeting
Agenda : Audited Result
27 Jun 2024
12:00 AM
BookCloser
3 Jan 2024
12:00 AM
Rights
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 55.37 | 27.69 | 27.69 | 27.69 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 9.2 | -12.36 | -12.32 | -7.02 |
Net Worth | 64.57 | 15.33 | 15.37 | 20.67 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 21.3 | 16.5 | 0.08 | 0.47 |
yoy growth (%) | 29.12 | 20,146.99 | -82.94 | 0 |
Raw materials | -19.2 | -15.23 | 0 | -0.41 |
As % of sales | 90.11 | 92.33 | 0 | 86.94 |
Employee costs | -0.18 | -0.12 | -0.01 | 0 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 1.5 | 1.2 | 0.06 | 0.01 |
Depreciation | -0.01 | 0 | 0 | 0 |
Tax paid | -0.25 | -0.19 | -0.01 | 0 |
Working capital | 4.08 | 7.76 | -0.02 | 0.09 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 29.12 | 20,146.99 | -82.94 | 0 |
Op profit growth | 84.44 | -2,632.19 | -56.97 | -43.54 |
EBIT growth | 25.23 | 1,775.51 | 389.08 | -175.99 |
Net profit growth | 24.57 | 2,016.97 | 210.4 | -84.48 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 |
|---|---|---|
Gross Sales | 30.41 | 25.52 |
Excise Duty | 0 | 0 |
Net Sales | 30.41 | 25.52 |
Other Operating Income | 0 | 0 |
Other Income | 0.66 | 0.1 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Adani Enterprises Ltd ADANIENT | 2,251.75 | 97.69 | 2,59,892.65 | 4,275.39 | 0.06 | 6,164.55 | 231.32 |
Aegis Logistics Ltd AEGISLOG | 797.05 | 65.17 | 27,976.46 | 65.79 | 0.82 | 672.12 | 71.38 |
Redington Ltd REDINGTON | 259.9 | 14.57 | 20,318.32 | 460.56 | 2.39 | 13,094.86 | 50.08 |
Cello World Ltd CELLO | 535.35 | 139.05 | 11,825.08 | 26.61 | 0.27 | 291.34 | 64.86 |
Honasa Consumer Ltd HONASA | 245.95 | 117.12 | 7,997.89 | 21.58 | 0 | 470.55 | 35.45 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non-Exec & Non-Independent Dir
Rajesh Sadhwani
Non-Exec & Non-Independent Dir
Sneha Sadhwani
Independent Non Exe. Director
Siddhesh Shankar Shende
Independent Director
Mayur Bharatbhai Bhatt
Independent Director
Sachin Aphandkar
Whole Time Director & CFO
Mr. Sohan Chaturvedi
Company Sec. & Compli. Officer
Hardik Makwana
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Genpharmasec Ltd
Summary
Genpharmasec Limited was originally incorporated as Public Limited Company on 16th November, 1992 in the State of Gujarat as Adi Rasayan Limited. The Company had received Certificate for Commencement of Business from ROC, Gujarat on November 20, 1992. Further, the name of Company was changed from Adi Rayasan Limited to Genpharmasec Limited on 27th November, 2018. Thereafter, the name of the Company was once again changed from Generic Pharmasec Limited to Genpharmasec Limited on 25th October, 2021 a fresh Certificate of Incorporation consequent upon the name change was obtained from the Registrar of Companies at Mumbai.The company implemented a project to manufacture organic and inorganic chemicals, dyes and pigments, at Panoli, Gujarat. Initially, the Company started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and from 2018 onwards, ity shifted business activities to buying, selling and distribution of all kinds of pharmaceutical, medicinal and medicated preparations and decided to venture into the securities market. In year 2019, the Company focused to the lucrative medical and diagnostics device segment. The Company tied up with Abbott Point of Care Corporation INC, USA for distribution of their niche diagnostic equipment namely, i-STAT 1 Analyzer which is a hand-held blood analyzer exclusively used in ICUs and ICCUs of hospitals for immediate test results.
Read More
What is the Genpharmasec Ltd share price today?
The Genpharmasec Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹1.96 today.
What is the Market Cap of Genpharmasec Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Genpharmasec Ltd is ₹108.53 Cr. as of 09 May ‘25
What is the PE and PB ratio of Genpharmasec Ltd?
The PE and PB ratios of Genpharmasec Ltd is 40.4 and 1.69 as of 09 May ‘25
What is the 52 Week High and Low of Genpharmasec Ltd?
The 52-week high/low is the highest and lowest price at which a Genpharmasec Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Genpharmasec Ltd is ₹1.89 and ₹4.32 as of 09 May ‘25
What is the CAGR of Genpharmasec Ltd?
Genpharmasec Ltd's CAGR for 5 Years at -23.95%, 3 Years at -14.04%, 1 Year at -0.98%, 6 Month at -33.11%, 3 Month at -11.79% and 1 Month at 1.51%.
What is the shareholding pattern of Genpharmasec Ltd?
The shareholding pattern of Genpharmasec Ltd is as follows:
Promoters - 29.98 %
Institutions - 0.00 %
Public - 70.02 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
